Sovran Advisors, LLC CLDX Holdings History

Number of Shares
-
Current Holdings Value*
N/A
% of Portfolio
0%
Total Estimate Gain
$-538,920.75
% of Total Estimate Gain
-17.53%

Sovran Advisors, LLC's Celldex Therapeutics Inc Holding Summary

As of 2025-03-31, Sovran Advisors, LLC held - shares of Celldex Therapeutics Inc(CLDX), totaling N/A. This investment constitutes 0% of their stock portfolio, and Sovran Advisors, LLC now holds 0% of the outstanding Celldex Therapeutics Inc(CLDX) stock.

The initial trade took place in 2024Q4. In addition, there have been 1 sales at an average price of $22.34 for 113,457.00 shares. Based on historical transaction data and CLDX's current price of $22.00, Sovran Advisors, LLC's estimated gain on his CLDX holdings is $-538,920.75, reflecting a -17.53% gain to date.

Sovran Advisors, LLC CLDX ($22.00) Holding Chart

Sovran Advisors, LLC CLDX ($22.00) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1